This publication is intended as an educational resource for New Zealand health professionals managing patients with heart failure. The focus of this publication is on what is new in the 2023 focused update to the 2021 European Society of Cardiology (ESC) guidelines for the diagnosis and treatment of acute and chronic heart failure, and a comparison with the 2022 guideline for the management of heart failure from the American College of Cardiology (ACC), American Heart Association (AHA) and the Heart Failure Society of America (HFSA). This review is supported by an independent educational grant from Boehringer Ingelheim and Eli Lilly.
Please login below to download this issue (PDF)